Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tacrolimus (Fujimycin) 可与 FKBP12 结合形成高亲和力复合物 (Ki: 0.2 nM),抑制钙/钙调蛋白依赖性蛋白磷酸酶的活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
10 mg | ¥ 263 | 现货 | ||
25 mg | ¥ 423 | 现货 | ||
50 mg | ¥ 587 | 现货 | ||
100 mg | ¥ 936 | 现货 | ||
200 mg | ¥ 1,470 | 现货 | ||
500 mg | ¥ 2,670 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 391 | 现货 |
产品描述 | Tacrolimus (Fujimycin) can bind FKBP12 to form a high-affinity complex (Ki: 0.2 nM) which inhibits the activity of the calcium/calmodulin-dependent protein phosphatase. |
靶点活性 | FKBP12:0.2 nM (Kd) |
体外活性 | FKBP12 was first isolated from the cytosol of Jurkat T cells, as an abundant, high-affinity receptor for Tacrolimus (FK506; Kd: 0.2 nM) [1]. FK506 (100?1,000 μg/l) significantly promoted the proliferation of MH3924A cells. The invasiveness of MH3924A cells was significantly enhanced following treatment with FK506 [2]. FK506 specifically inhibits cellular calcineurin at drug concentrations that inhibit interleukin 2 productions in activated T cells [3]. |
体内活性 | The liver of rats of the normal saline (NS) group was large, with an average weight at 15.56±11.17 g, and the liver of rats of the FK506 group was oversize, with an average weight at 28.19±3.89 g. The rate of lymph node metastasis, as well as the number of pulmonary nodules, were significantly increased in the FK506 compared to the NS group [2]. Behavioral pain assessment revealed an increase in the paw and tail withdrawal threshold in tacrolimus-treated groups against hyperalgesic and allodynic stimuli as compared to the sham control group [4]. |
细胞实验 | Tumor cell proliferation was determined by the MTT. Briefly, after MH3924A cells had reached the logarithmic growth phase, a 0.2-ml cell suspension at 1×10^4 cells/ml was added into each well of a 96-well plate and cultured in DMEM with 10% FBS, 10 μg/l vascular endothelial growth factor and 0.1 g/l heparin for 24 h. When adherent growth was established, different concentrations of FK506 (10, 100 and 1,000 μg/l), AMD3100 (10, 50 and 100 μg/l) and FK506 (0 and 100 μg/l) + AMD3100 (0, 10, 50 and 100 μg/l) were added into the plates. Untreated cells cultured in medium alone were used as controls. After culturing for 48 h, 10 μl MTT (5 g/l) was added, and each well was incubated for 6 h; next, 150 μl/well dimethyl sulfoxide was added, followed by measurements of the absorbance at 570 mm on a spectrophotometer reader. Each well was measured three times, and each sample was assayed in triplicate [2]. |
动物实验 | Experiments were performed in 16 healthy August Copenhagen Irish rats (male, 16–20 weeks, weighing 240–300 g). The rat model of liver tumor was established as follows: First, MH3924A cells were collected and injected into the alar skin of rats. The tumors were removed from alar skin when grown to 2×1×1 mm3, and intrahepatic tumor implantation of rats was performed under aseptic conditions as described previously (25,26). Five days later, rats were randomly divided into two groups: one group was subcutaneously injected with normal saline for 14 days (NS group, n=8, 3 mg/kg/day), and the second group was subcutaneously injected with FK506 for 14 days (FK506 group, n=8, 0.3 mg/kg/day). Forty days following implantation, rats were sacrificed, and the weight of tumor, the volume of the fluid in the ascites, the incidence of lymphatic metastasis in the abdominal cavity and of abdominal wall metastasis were measured. In addition, the lungs were irrigated with 15% Indian ink, followed by counting of the number of metastatic nodules in the lung. The tumor and adjacent tissues, as well as healthy liver tissues, were harvested and preserved in 4% formalin for later use [2]. |
别名 | 他克莫司, Fujimycin, FK506, FR900506 |
分子量 | 804.02 |
分子式 | C44H69NO12 |
CAS No. | 104987-11-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 80.4 mg/mL (100 mM)
DMSO: 80.4 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 1.2438 mL | 6.2188 mL | 12.4375 mL | 31.0938 mL |
5 mM | 0.2488 mL | 1.2438 mL | 2.4875 mL | 6.2188 mL | |
10 mM | 0.1244 mL | 0.6219 mL | 1.2438 mL | 3.1094 mL | |
20 mM | 0.0622 mL | 0.3109 mL | 0.6219 mL | 1.5547 mL | |
50 mM | 0.0249 mL | 0.1244 mL | 0.2488 mL | 0.6219 mL | |
100 mM | 0.0124 mL | 0.0622 mL | 0.1244 mL | 0.3109 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Tacrolimus 104987-11-3 Autophagy Metabolism Microbiology/Virology Others PI3K/Akt/mTOR signaling Phosphatase Antibacterial Antibiotic mTOR 他克莫司 FKBP FK506-binding protein Inhibitor Fujimycin Bacterial FR-900506 FK 506 FK506 FK-506 inhibit FR 900506 FR900506 inhibitor